Actively Recruiting
Collection of Endometrial Cancer-derived Organoids to Evaluate the Efficacy of PARP Inhibitors: PENDOR Pilot Study
Led by Centre Francois Baclesse · Updated on 2024-11-26
16
Participants Needed
1
Research Sites
151 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study comprises 3 stages: 1. Collection of tumor and blood samples. 2. Creation of organoid models based on tumor samples. 3. Development of functional tests to predict clinical response to treatment.
CONDITIONS
Official Title
Collection of Endometrial Cancer-derived Organoids to Evaluate the Efficacy of PARP Inhibitors: PENDOR Pilot Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient aged 18 years or more
- Patient with histologically confirmed, localized endometrial cancer, candidate for surgical treatment
- Patient with localized endometrial cancer presenting a high-grade endometrioid histological type and/or P53 mutation and/or a non-endometrioid histological type regardless of P53 status
- Patient affiliated to a social security scheme
- Information and signature of informed consent prior to any specific study procedure
You will not qualify if you...
- Other active cancer less than 6 months old (except treated basal cell carcinoma of the skin)
- Patient deprived of liberty, under guardianship, or subject to a legal protection measure, or unable to express consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre François Baclesse
Caen, France
Actively Recruiting
Research Team
G
Gwenn LE GALL, Medical Doctor
CONTACT
F
François CHERIFI, Medical Doctor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here